Karen Bernstein is Director at Ovid Therapeutics Inc. (OVID). They have made 2 open-market trades across 1 company since 2018, most recently 2023-02-16.
CIK 0001654055
2 open-market purchases totalling $145K since 2018, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.